Nov 2023 Synthetic Stimulants
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Clinical Update
Sep 2023 Designer Benzodiazepines
Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight...
Aug 2023 Synthetic Cannabinoids
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
Mar 2023 Novel Psychoactive Substances: Newly Identified Threats Detected in the Second Half of 2022
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Jan 2023 Novel Psychoactive Substances: What is Xylazine?
Substance use can take many forms and often involves many unknowns. One of the most important aspects of illicit substance...
Nov 2022 Aegis’s Novel Psychoactive Substances Testing Menu Update
In September, Aegis updated both urine and oral fluid novel psychoactive substance (NPS) test menus as a continued commitment to...
